These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 27123798)

  • 1. Buprenorphine Prescribing: To Expand or Not to Expand.
    Li X; Shorter D; Kosten TR
    J Psychiatr Pract; 2016 May; 22(3):183-92. PubMed ID: 27123798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buprenorphine Therapy for Opioid Use Disorder.
    Zoorob R; Kowalchuk A; Mejia de Grubb M
    Am Fam Physician; 2018 Mar; 97(5):313-320. PubMed ID: 29671504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SAMHSA outlines how to treat addiction to prescription painkillers and heroin in physicians' offices.
    Conn Med; 2003 Feb; 67(2):103-4. PubMed ID: 12664838
    [No Abstract]   [Full Text] [Related]  

  • 4. Buprenorphine in the treatment of opioid addiction: opportunities, challenges and strategies.
    Li X; Shorter D; Kosten TR
    Expert Opin Pharmacother; 2014 Oct; 15(15):2263-75. PubMed ID: 25171726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nurse Practitioner Prescriptive Authority for Buprenorphine: From DATA 2000 to CARA 2016.
    Fornili KS; Fogger SA
    J Addict Nurs; 2017; 28(1):43-48. PubMed ID: 28252511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buprenorphine: effective treatment of opioid addiction starts in the office.
    Fiellin DA
    Am Fam Physician; 2006 May; 73(9):1513-4. PubMed ID: 16719242
    [No Abstract]   [Full Text] [Related]  

  • 7. Geographic and specialty distribution of US physicians trained to treat opioid use disorder.
    Rosenblatt RA; Andrilla CH; Catlin M; Larson EH
    Ann Fam Med; 2015; 13(1):23-6. PubMed ID: 25583888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties.
    Stein BD; Pacula RL; Gordon AJ; Burns RM; Leslie DL; Sorbero MJ; Bauhoff S; Mandell TW; Dick AW
    Milbank Q; 2015 Sep; 93(3):561-83. PubMed ID: 26350930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing opioid addiction with buprenorphine.
    Donaher PA; Welsh C
    Am Fam Physician; 2006 May; 73(9):1573-8. PubMed ID: 16719249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using buprenorphine to treat patients with opioid use disorder.
    Radi JK; Fogarty KJ; Lagerwey MD
    JAAPA; 2019 Oct; 32(10):30-35. PubMed ID: 31513035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of DATA 2000 certification trainings for the provision of buprenorphine treatment in the Veterans Health Administration.
    Gordon AJ; Liberto J; Granda S; Salmon-Cox S; Andree T; McNicholas L
    Am J Addict; 2008; 17(6):459-62. PubMed ID: 19034736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentration of Patient Care Among Buprenorphine-Prescribing Clinicians in the US.
    Stein BD; Saloner B; Schuler MS; Gurvey J; Sorbero M; Gordon AJ
    JAMA; 2021 Jun; 325(21):2206-2208. PubMed ID: 34061152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addiction to prescription opioids: characteristics of the emerging epidemic and treatment with buprenorphine.
    Mendelson J; Flower K; Pletcher MJ; Galloway GP
    Exp Clin Psychopharmacol; 2008 Oct; 16(5):435-41. PubMed ID: 18837640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanding treatment capacity for opioid dependence with office-based treatment with buprenorphine: National surveys of physicians.
    Arfken CL; Johanson CE; di Menza S; Schuster CR
    J Subst Abuse Treat; 2010 Sep; 39(2):96-104. PubMed ID: 20598829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buprenorphine prescribing by APRNs.
    Rundio A
    J Addict Nurs; 2012 Feb; 23(1):80-1. PubMed ID: 22468666
    [No Abstract]   [Full Text] [Related]  

  • 16. Buprenorphine diversion and misuse in outpatient practice.
    Lofwall MR; Martin J; Tierney M; Fatséas M; Auriacombe M; Lintzeris N
    J Addict Med; 2014; 8(5):327-32. PubMed ID: 25221985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Buprenorphine to Treat Opioid Use Disorder.
    Bartholow LAM; Pope J
    J Psychosoc Nurs Ment Health Serv; 2018 Nov; 56(11):9-12. PubMed ID: 30383881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nurse Practitioner and Physician Assistant Waivers to Prescribe Buprenorphine and State Scope of Practice Restrictions.
    Spetz J; Toretsky C; Chapman S; Phoenix B; Tierney M
    JAMA; 2019 Apr; 321(14):1407-1408. PubMed ID: 30964519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescription drug monitoring programs and buprenorphine maintenance: clinical considerations.
    Hoefer M; Petrakis I
    Am J Addict; 2014; 23(6):616-7. PubMed ID: 25251308
    [No Abstract]   [Full Text] [Related]  

  • 20. How Massachusetts, Vermont, and New York Are Taking Action to Address the Opioid Epidemic.
    Hernandez Y; Meyers-Ohki S; Farkas S; Ball S; Leonard K; Rotrosen J; Saitz R
    Am J Public Health; 2018 Dec; 108(12):1621-1622. PubMed ID: 30403507
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.